KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Quest Diagnostics (DGX) Long-Term Debt Issuances: 2009-2025

Historic Long-Term Debt Issuances for Quest Diagnostics (DGX) over the last 10 years, with Sep 2025 value amounting to $10.0 million.

  • Quest Diagnostics' Long-Term Debt Issuances fell 99.46% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year decrease of 47.51%. This contributed to the annual value of $1.8 billion for FY2024, which is 28.78% down from last year.
  • Per Quest Diagnostics' latest filing, its Long-Term Debt Issuances stood at $10.0 million for Q3 2025, which was down 94.59% from $185.0 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Long-Term Debt Issuances peaked at $1.8 billion during Q3 2024, and registered a low of $10.0 million during Q3 2025.
  • Over the past 3 years, Quest Diagnostics' median Long-Term Debt Issuances value was $385.5 million (recorded in 2023), while the average stood at $606.0 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first surged by 232.01% in 2024, then crashed by 99.46% in 2025.
  • Quest Diagnostics' Long-Term Debt Issuances (Quarterly) stood at $889.0 million in 2023, then skyrocketed by 232.01% to $1.8 billion in 2024, then crashed by 99.46% to $10.0 million in 2025.
  • Its Long-Term Debt Issuances stands at $10.0 million for Q3 2025, versus $185.0 million for Q2 2025 and $215.0 million for Q1 2025.